Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1263 USD | +2.52% | -7.00% | -9.79% |
Financials (USD)
Sales 2022 | 32.26M | Sales 2023 | 34.16M | Capitalization | 29.4M |
---|---|---|---|---|---|
Net income 2022 | 8M | Net income 2023 | 3M | EV / Sales 2022 | 0.92 x |
Net cash position 2022 | 5.75M | Net cash position 2023 | 3.94M | EV / Sales 2023 | 0.75 x |
P/E ratio 2022 |
4.73
x | P/E ratio 2023 |
9.34
x | Employees | 53 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.76% |
Latest transcript on Elite Pharmaceuticals, Inc.
1 day | +2.52% | ||
1 week | -7.00% | ||
Current month | -18.15% | ||
1 month | -16.47% | ||
3 months | -36.12% | ||
6 months | -12.78% | ||
Current year | -9.79% |
Managers | Title | Age | Since |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 13-07-31 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 09-06-30 |
Christopher Dick
PSD | President | 69 | 02-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 09-10-22 |
Barry Dash
BRD | Director/Board Member | 93 | 05-03-31 |
Davis Caskey
BRD | Director/Board Member | 76 | 16-04-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.1263 | +2.52% | 1,124,880 |
24-04-23 | 0.1232 | -3.14% | 798,573 |
24-04-22 | 0.1272 | -2.15% | 611,836 |
24-04-19 | 0.13 | -2.62% | 731,258 |
24-04-18 | 0.1335 | -1.69% | 85,713 |
Delayed Quote OTC Markets, April 24, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-9.79% | 132M | |
+17.97% | 42.77B | |
+19.40% | 22.23B | |
+13.12% | 14.44B | |
+12.19% | 13.05B | |
+35.45% | 11.59B | |
-8.96% | 6.95B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.29% | 4.97B |
- Stock Market
- Equities
- ELTP Stock